It’s Time to End Forced Sterilization—And Write a New Reproductive Equity Story by and for Disabled People
By Ma’ayan Anafi,
National Women's Law Center
| 05. 22. 2024
Just under a century ago this May, the Supreme Court handed down an infamous ruling upholding a Virginia law that allowed the forced sterilization of a woman named Carrie Buck. In doing so, it offered its full-throated approval for the ongoing mass sterilizations that were happening all over the country. During the heyday of the eugenics movement, nearly 70,000 people were sterilized against their will—mostly people who were, like Carrie Buck, disabled or perceived as such, and disproportionately Black and brown women.
The story that we’re told about forced sterilization—if we’re told the story at all—is that it was confined to that dark period in history, rising and falling with the popularity of eugenics. But the truth is that forced sterilization is far from a thing of the past. Laws allowing the forced sterilization of disabled people exist right now, all over the country. As we revealed in a 2022 report, the majority of states—31 plus Washington, D.C.,—have laws in place allowing the forced sterilization of disabled people today.
These laws aren’t eugenics-era relics still kicking around from a...
Related Articles
By Vittoria Vardanega, SWI swissinfo.ch | 02.13.2026
In recent years, sperm donation has produced family trees of unprecedented size, stretching across countries and, in some cases, continents. Stories of “mass donors” have captured public attention, most recently through the Netflix documentary series, The Man with 1,000 Kids...
By Jonathan D. Moreno, Hastings Center Bioethics Forum | 02.09.2026
When I began to write a book about bioethics and the rules-based international order, the idea that the world was facing the greatest geopolitical change since World War II was uncontroversial for those who were paying attention to such esoterica...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...